Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi

被引：28
|
作者：
Luminari, Stefano [1 ]
Galimberti, Sara [2 ]
Versari, Annibale [3 ]
Biasoli, Irene [4 ]
Anastasia, Antonella [5 ]
Rusconi, Chiara [6 ]
Ferrari, Angela [7 ]
Petrini, Mario [2 ]
Manni, Martina [1 ]
Federico, Massimo [1 ]
机构：
[1] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, MO, Italy
[2] Univ Pisa, UO Hematol, Dept Internal & Expt Med, I-56100 Pisa, Italy
[3] Arcispedale S Maria Nuova IRCCS Reggio Emilia, Dept Nucl Med, Reggio Emilia, Italy
[4] Univ Fed Rio de Janeiro, Univ Hosp & Sch Med, Dept Med, BR-21941 Rio De Janeiro, Brazil
[5] Spedali Civil Brescia, Hematol Unit, Brescia, Italy
[6] Osped Niguarda Ca Granda, Div Hematol, Dept Hematol & Oncol, Milan, Italy
[7] IRCCS Reggio Emilia, Arcispedale Santa Maria Nuova, Hematol Unit, Reggio Emilia, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷 / 02期
关键词：
follicular lymphoma; minimal residual disease; nuclear medicine; FDG-PET; progression-free survival; B-CELL LYMPHOMA; PET; CT;
D O I：
10.3324/haematol.2015.132811
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E66 / E68
页数：3
相关论文
共 7 条
  • [1] The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)
    Luminari, S.
    Biasoli, I.
    Versari, A.
    Rattotti, S.
    Bottelli, C.
    Rusconi, C.
    Merli, F.
    Spina, M.
    Ferreri, A. J. M.
    Zinzani, P. L.
    Gallamini, A.
    Franceschetto, A.
    Boccomini, C.
    Franceschetti, S.
    Salvi, F.
    Raimondo, F. D.
    Carella, A. M.
    Micol, Q.
    Balzarotti, M.
    Musto, P.
    Federico, M.
    ANNALS OF ONCOLOGY, 2014, 25 (02) : 442 - 447
  • [2] The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi
    Luminari, S.
    Biasoli, I.
    Arcaini, L.
    Versari, A.
    Rusconi, C.
    Merli, F.
    Spina, M.
    Ferreri, A. J. M.
    Zinzani, P. L.
    Gallamini, A.
    Mastronardi, S.
    Boccomini, C.
    Gaidano, G.
    D'Arco, A. M.
    Di Raimondo, F.
    Carella, A. M.
    Santoro, A.
    Musto, P.
    Federico, M.
    ANNALS OF ONCOLOGY, 2013, 24 (08) : 2108 - 2112
  • [3] Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi
    Marcheselli, Luigi
    Bari, Alessia
    Anastasia, Antonella
    Botto, Barbara
    Puccini, Benedetta
    Dondi, Alessandra
    Carella, Angelo M.
    Alvarez, Isabel
    Chiarenza, Annalisa
    Arcari, Annalisa
    Salvi, Flavia
    Federico, Massimo
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (04) : 544 - 551
  • [4] Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naive advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi
    Nizzoli, Maria E.
    Manni, Martina
    Ghiggi, Chiara
    Pulsoni, Alessandro
    Musuraca, Gerardo
    Merli, Michele
    Califano, Catello
    Bari, Alessia
    Massaia, Massimo
    Conconi, Annarita
    Musto, Pellegrino
    Mannina, Donato
    Perrone, Tommasina
    Re, Francesca
    Galimberti, Sara
    Gini, Guido
    Capponi, Monia
    Vitolo, Umberto
    Usai, Sara V.
    Stefani, Piero M.
    Ballerini, Filippo
    Liberati, Anna M.
    Pennese, Elsa
    Pastore, Domenico
    Skrypets, Tetiana
    Catellani, Hillary
    Marcheselli, Luigi
    Federico, Massimo
    Luminari, Stefano
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (04) : 655 - 662
  • [5] End of induction positron emission tomography complete response (PET-CR) as a surrogate for progression-free survival in previously untreated follicular lymphoma
    Dixon, Jesse G.
    Dimier, Natalie
    Nielsen, Tina
    Zheng, Jamie
    Marcus, Robert
    Morschhauser, Franck
    Evens, Andrew M.
    Federico, Massimo
    Blum, Kristie A.
    Shi, Qian
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (02) : 333 - 337
  • [6] Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival
    Dai, Na
    Liu, Hang
    Deng, Shengming
    Sang, Shibiao
    Wu, Yiwei
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [7] Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation
    Varghese, Abraham M.
    Howard, Dena R.
    Pocock, Christopher
    Rawstron, Andy C.
    Follows, George
    McCarthy, Helen
    Dearden, Claire
    Fegan, Christopher
    Milligan, Donald
    Smith, Alexandra F.
    Gregory, Walter
    Hillmen, Peter
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (04) : 573 - 582
1